Cargando…
Home treatment in paediatric patients with Hunter syndrome: the first Italian experience
Hunter syndrome (mucopolysaccharidosis type II [MPS II], OMIM309900) is a rare X-linked lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulphatase, resulting in accumulation of glycosaminoglycans, progressive multisystem organ failure, and early death. Enzyme replacemen...
Autores principales: | Ceravolo, Ferdinando, Mascaro, Italia, Sestito, Simona, Pascale, Elisa, Lauricella, Antonino, Dizione, Elio, Concolino, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847888/ https://www.ncbi.nlm.nih.gov/pubmed/24011228 http://dx.doi.org/10.1186/1824-7288-39-53 |
Ejemplares similares
-
Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report
por: Ceravolo, Ferdinando, et al.
Publicado: (2017) -
Clinical efficacy of Enzyme Replacement Therapy in paediatric Hunter patients, an independent study of 3.5 years
por: Tomanin, Rosella, et al.
Publicado: (2014) -
The Homes of John Hunter in London
por: Packard, Francis R.
Publicado: (1929) -
The hypnic headache syndrome: the first description of an Italian case
por: Zanchin, Giorgio, et al.
Publicado: (2000) -
Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study
por: Sestito, Simona, et al.
Publicado: (2022)